SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950142-24-000548
Filing Date
2024-02-26
Accepted
2024-02-26 16:53:55
Documents
2
Group Members
ATLAS NEON MERGER SUB, INCATLAS NEON PARENT, INC.COLUMN GROUP GP, LPCOLUMN GROUP II GP, LPCOLUMN GROUP II, LPCOLUMN GROUP III GP, LPCOLUMN GROUP III, LPCOLUMN GROUP III-A, LPCOLUMN GROUP IV GP, LPCOLUMN GROUP IV, LPCOLUMN GROUP IV-A, LPCOLUMN GROUP MANAGE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE TO-C eh240451718_sctoc.htm SC TO-C 27991
2 EXHIBIT 99.1 eh240451718_ex9901.htm EX-99.1 18108
  Complete submission text file 0000950142-24-000548.txt   48555
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
COLUMN GROUP L P (Filed by) CIK: 0001347769 (see all company filings)

IRS No.: 000000000
Type: SC TO-C

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Subject) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90978 | Film No.: 24679855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)